The federal government and a number of states have decided to intervene in a whistleblower lawsuit that accuses Pfizer’s Wyeth unit of giving kickbacks to doctors to encourage them to…
Federal prosecutors have opened a criminal investigation into Wyeth’s promotions and marketing activities involving the organ transplant drug Rapamune.
The FDA has issued a warning to transplant doctors that switching their patients to the anti-organ transplant rejection drug Rapamune after a liver transplant may increase the risk of death.
Recent research suggests that Rapamune, also known as sirolimus, may increase the risk of diabetes after a kidney transplant. This is a serious health concern, and could lead to kidney…
